Correlation Between Central China and Jafron Biomedical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Central China and Jafron Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Central China and Jafron Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Central China Land and Jafron Biomedical Co, you can compare the effects of market volatilities on Central China and Jafron Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Central China with a short position of Jafron Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Central China and Jafron Biomedical.

Diversification Opportunities for Central China and Jafron Biomedical

0.7
  Correlation Coefficient

Poor diversification

The 3 months correlation between Central and Jafron is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Central China Land and Jafron Biomedical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Jafron Biomedical and Central China is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Central China Land are associated (or correlated) with Jafron Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Jafron Biomedical has no effect on the direction of Central China i.e., Central China and Jafron Biomedical go up and down completely randomly.

Pair Corralation between Central China and Jafron Biomedical

Assuming the 90 days trading horizon Central China Land is expected to generate 0.78 times more return on investment than Jafron Biomedical. However, Central China Land is 1.28 times less risky than Jafron Biomedical. It trades about 0.06 of its potential returns per unit of risk. Jafron Biomedical Co is currently generating about 0.04 per unit of risk. If you would invest  966.00  in Central China Land on September 3, 2024 and sell it today you would earn a total of  136.00  from holding Central China Land or generate 14.08% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Central China Land  vs.  Jafron Biomedical Co

 Performance 
       Timeline  
Central China Land 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Central China Land are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Central China is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Jafron Biomedical 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Jafron Biomedical Co are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Jafron Biomedical sustained solid returns over the last few months and may actually be approaching a breakup point.

Central China and Jafron Biomedical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Central China and Jafron Biomedical

The main advantage of trading using opposite Central China and Jafron Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Central China position performs unexpectedly, Jafron Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jafron Biomedical will offset losses from the drop in Jafron Biomedical's long position.
The idea behind Central China Land and Jafron Biomedical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Commodity Directory
Find actively traded commodities issued by global exchanges